VeriMomDois-je éviter cannabigerol pendant la grossesse ? | VeriMom
No harmonised (Annex VI CLP) reproductive classification for cannabigerol (CBG) was identified; ECHA InfoCard shows company C&L notifications reporting H361d but this appears to come from C&L notifications rather than a legally harmonised CLH entry, and there are no CIR or SCCS safety opinions specific to CBG. Cannabinoids as a class (e.g., THC/CBD) have been associated with developmental effects in animal and human studies, giving a plausible class-based mechanism, but direct reproductive/teratogenic data for CBG are lacking; dermal absorption is plausible and likely low-but-measurable for a small lipophilic phytocannabinoid. (See ECHA InfoCard; PubChem; human/animal cannabinoid developmental reviews.).
ECHA regulatory hazard statements
- •H361D
What to use instead
Pregnancy-safe ingredients that serve a similar function:
FAQ
- cannabigerol est-il sûr pendant la grossesse ?
- No harmonised (Annex VI CLP) reproductive classification for cannabigerol (CBG) was identified; ECHA InfoCard shows company C&L notifications reporting H361d but this appears to come from C&L notifications rather than a legally harmonised CLH entry, and there are no CIR or SCCS safety opinions specific to CBG. Cannabinoids as a class (e.g., THC/CBD) have been associated with developmental effects in animal and human studies, giving a plausible class-based mechanism, but direct reproductive/teratogenic data for CBG are lacking; dermal absorption is plausible and likely low-but-measurable for a small lipophilic phytocannabinoid. (See ECHA InfoCard; PubChem; human/animal cannabinoid developmental reviews.).
- cannabigerol est-il sûr pendant l'allaitement ?
- There are no authoritative safety assessments (CIR/SCCS/harmonised CLP) specifically identifying CBG as a confirmed reproductive or lactation hazard. Cannabinoids can be transferred to milk (class concern from THC/CBD literature) so a theoretical class-based mechanism exists, but direct studies on CBG transfer in human milk or lactation-specific toxicity are not found; topical cosmetic use would give low but measurable maternal systemic exposure in some scenarios, so breastfeeding exposure is possible but not characterized for CBG.
- cannabigerol est-il sûr pour la peau de bébé ?
- No infant-specific toxicity or safety data for topical CBG were identified. By class-based analogy to other cannabinoids there is a theoretical mechanism, but no direct evidence that CBG causes reproductive/infant toxicity. Because infant skin has higher absorption per kg, exposure score is increased by +1 compared with adults when measurable dermal absorption is plausible; direct dermal absorption studies for CBG were not found.
- Comment VeriMom évalue-t-il cannabigerol ?
- VeriMom évalue cannabigerol à 27/100 (risque élevé) sur la base du statut EU CosIng, des classifications ECHA et des études PubMed.
- Quelles sont les alternatives sûres à cannabigerol pendant la grossesse ?
- Consultez notre liste d'alternatives sûres à cannabigerol basée sur une fonction similaire et une classification sans risques connus.
Vérifiez chaque étiquette en 2 secondes
Obtenez VeriMom gratuitement — scannez n'importe quel produit et voyez le score de sécurité grossesse instantanément.
Avis Médical
Ces informations sont fournies à titre éducatif uniquement et ne constituent pas un avis médical. Les scores de sécurité sont basés sur des données accessibles au public et peuvent ne pas refléter tous les risques. Consultez toujours votre professionnel de santé avant d'utiliser tout produit pendant la grossesse ou l'allaitement.